Institute of Pathology, Heidelberg University Hospital, Universitätsklinikum Heidelberg, Pathologisches Institut, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
German Center for Infection Research (DZIF), partner site Heidelberg, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Clin Res Cardiol. 2023 Mar;112(3):431-440. doi: 10.1007/s00392-022-02129-5. Epub 2022 Nov 27.
Cases of myocarditis, diagnosed clinically by laboratory tests and imaging have been described in the context of mRNA-based anti-SARS-CoV-2 vaccination. Autopsy-based description of detailed histological features of vaccine-induced myocarditis is lacking. We describe the autopsy findings and common characteristics of myocarditis in untreated persons who received anti-SARS-CoV-2 vaccination. Standardized autopsies were performed on 25 persons who had died unexpectedly and within 20 days after anti-SARS-CoV-2 vaccination. In four patients who received a mRNA vaccination, we identified acute (epi-)myocarditis without detection of another significant disease or health constellation that may have caused an unexpected death. Histology showed patchy interstitial myocardial T-lymphocytic infiltration, predominantly of the CD4 positive subset, associated with mild myocyte damage. Overall, autopsy findings indicated death due to acute arrhythmogenic cardiac failure. Thus, myocarditis can be a potentially lethal complication following mRNA-based anti-SARS-CoV-2 vaccination. Our findings may aid in adequately diagnosing unclear cases after vaccination and in establishing a timely diagnosis in vivo, thus, providing the framework for adequate monitoring and early treatment of severe clinical cases.
已在接受基于 mRNA 的抗 SARS-CoV-2 疫苗接种的情况下描述了通过实验室检测和影像学诊断的心肌炎病例。缺乏基于尸检的疫苗引起的心肌炎详细组织学特征的描述。我们描述了未经治疗的接受抗 SARS-CoV-2 疫苗接种者的心包炎的尸检结果和常见特征。对 25 名在接受抗 SARS-CoV-2 疫苗接种后 20 天内意外死亡的人进行了标准化尸检。在接受 mRNA 疫苗接种的 4 名患者中,我们发现了急性(心外膜)心肌炎,未检测到其他可能导致意外死亡的重大疾病或健康状况。组织学显示局灶性间质性心肌 T 淋巴细胞浸润,主要为 CD4 阳性亚群,伴有轻度心肌损伤。总体而言,尸检结果表明死于急性心律失常性心力衰竭。因此,心肌炎可能是 mRNA 基抗 SARS-CoV-2 疫苗接种后的潜在致命并发症。我们的研究结果可能有助于在接种疫苗后对不明原因的病例进行充分诊断,并在体内及时诊断,从而为严重临床病例的充分监测和早期治疗提供框架。